| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8722503 | Digestive and Liver Disease | 2017 | 19 Pages |
Abstract
All 4 markers were excellent diagnostic panels to clearly discriminate BE from CLE. Moreover, as FABP1 and Hepar have different expression levels in dysplasia and EAC, these markers could function as key diagnostic aids in helping to determine the state of disease progression.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Supriya Srivastava, Florian Kern, Neel Sharma, Frank McKeon, Wa Xian, Khay Guan Yeoh, Khek Yu Ho, Ming Teh,